Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Open Access

The Importance that the Pediatrician Talks to the Children with a Parent Affected by Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MJMomcilo JankovicUniversity of Milano-BicoccaFGFrancesca GallinaMCMarina Elena CazzanigaAzienda Ospedaliera San Gerardo

Discussion

Loading...

Member takes

Implication

Observational analysis improved communication about cancer in families, suggesting psychosocial support is vital.

Key Points

  • Interventions led to a dramatic reduction of psychopathological symptoms in children.
  • Results showed improved collaboration among family members after engaging with the multidisciplinary team.
  • Approximately 73 children participated across multiple sessions with the pediatric hemato-oncologists and psychologists.
  • Findings underscore the importance of open communication about cancer-related issues among family members.

Cite This Study

Jankovic et al. (2025) studied this question.

synapsesocial.com/papers/68c241efb210217d647a1858https://doi.org/10.20944/preprints202508.0264.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Parental cancer: communication, daily life changes and psychosocial support: a qualitative study of adolescents and young adults who experienced parental cancer during adolescence2025
  2. 2“Suffering in Silence”: Caregiver and medical team experiences on psychosocial screening among pediatric patients with hematologic malignancies2025
  3. 3Ignite the Parent–Child Bond: A Qualitative Exploration of Perspective and Need About Family Functioning Among Patients With Advanced Cancer and Their Adolescent Children2025 · 3 citations
  4. 4Pediatric Oncology Care Providers' Attitudes On and Perceptions of Assent2019
  5. 5Effectiveness of a culturally adapted psychoeducational intervention for family caregivers of children with hematologic malignancy: a randomized controlled trial2026